CANCER MEDICAL TREATMENT

FIELD: medicine. ^ SUBSTANCE: 40-0-(2-hydroxiethyl)rapamycin is offered to apply in pharmaceutical formulation for inhibition and control of angiogenesis inadequate regulation or for related diseases. Specifically it is used for tumour treatment of brain, central nervous system, colon, rectum or rep...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LANE KHEJDI, VUD DZHINETTA MARDZHORI, O`REJLLI TERENS
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: 40-0-(2-hydroxiethyl)rapamycin is offered to apply in pharmaceutical formulation for inhibition and control of angiogenesis inadequate regulation or for related diseases. Specifically it is used for tumour treatment of brain, central nervous system, colon, rectum or reproductive system. ^ EFFECT: proliferation inhibition of vein endotheliocytes and proliferation inhibition stimulated by vascular endothelial growth factor. ^ 3 cl